Who is sponsoring NCT04619212?

NCT04619212 is sponsored by Medela AG.

What drugs are being tested in NCT04619212?

Interventions in NCT04619212: breast pumping as per SoC but on new software for the pump.

What condition does NCT04619212 study?

NCT04619212 studies Breast Pumping.

Is NCT04619212 still recruiting?

NCT04619212 is currently completed. Last updated 25 March 2024.

Last reviewed 2024-03-25 · How we verify

NCT04619212: Initiate

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Initiate Study Evaluating if Mothers Who Are Both Breastfeeding and Pumping in the First Days After Delivery Report Improved Comfort Levels With the New Symphony Program Card

Completed NA Last updated 25 March 2024

What this trial tests

NA trial testing breast pumping as per SoC but on new software for the pump in Breast Pumping in 80 participants. Completed in 7 September 2021.

Timeline

5 January 2021

Primary endpoint
7 September 2021

7 September 2021

Quick facts

Lead sponsor	Medela AG
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	80
Start date	5 January 2021
Primary completion	7 September 2021
Estimated completion	7 September 2021
Sites	1 location across Netherlands

Drugs / interventions tested

breast pumping as per SoC but on new software for the pump

Conditions studied

Breast Pumping — all drugs for Breast Pumping →

Sponsor

Medela AG

Who can join

18 and older, female only, with Breast Pumping. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study hypothesizes that mothers who are both breastfeeding and pumping in the first days report improved comfort levels with the new Symphony program card INITIATE 2.0 compared to the standard of care.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

An evaluation of patient comfort levels during expression with a modified pumping program: a prospective proof of concept study.
Manshanden TMN, Prime DK, Scheele F, Velzel J. · · 2024 · cited 1× · PMID 38707635 · DOI 10.3389/fgwh.2024.1378263
Impact of a Modified Breast Pump Suction Pattern on Milk Yield During the Initiation of Lactation: A pilot study.
Nicole Manshanden TM, Prime DK, Scheele F, Velzel J. · · 2026 · PMID 41276904 · DOI 10.1097/jpn.0000000000000975

Verify or expand the search:

Other Medela AG trials

Trials by the same sponsor.

NCT04593693 — A Dual-center Study Evaluating Clinical Acceptance of a NPWT Wound Care System · NA · completed
NCT03921918 — Evaluation of Fluid-Filled Expression Core Technology Study - I · NA · completed
NCT03670225 — Evaluating Clinical Acceptance of a NPWT Wound Care System · NA · completed
NCT03091985 — Influence of the Brownie Breast Shield on the Dynamics of Milk Removal · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04619212 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Medela AG
Last refreshed: 25 March 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04619212.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing